Join ILCA for the first webinar of the year covering the available data regarding the use of immunotherapy for HCC in the setting of liver transplantation, including any modification in the perioperative management.

Chairs: 
• Julie Heimbach, Director, William Von Liebig Center for Transplantation | Professor of Surgery | Mayo Clinic College of Medicine, US
• Olivier Rosmoduc, Hepatologist and liver oncologist in Hepato-Biliary Centre at Paul Brousse Hospital – Villejuif, France 
 
 Speakers:  
 
• Which patients to treat ?  Myron Schwartz, Clinical Director of the Mount Sinai Liver Cancer Program., New York, US
•      Which medications to use ? Ahmed Kaseb, Professor, Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
 
• When to start and when to stop systemic therapy ? Anjana Pillai, Medical Director of the multidisciplinary liver tumor program at UChicago Medicine, US
 
Free webinar for ILCA members.
40 € for ILCA non-members

Eisai has funded the webinar and all content has been developed independently by ILCA